Aller au contenu principal
Retour à l'annuaire
CL
Rhumatologue

Docteur CLEMENTINA LOPEZ MEDINA

RPPS 10102031787
Publications actives

121 publis sur 5 ans↘

📊 Reconnaissance scientifique : 25/100📝 287 articles publiés📚 HAL (8)

✨ Profil synthétique

IA · 06/05/2026

Le Docteur CLEMENTINA LOPEZ MEDINA est un rhumatologue avec une production scientifique significative, comme en témoignent ses 287 publications et un h-index de 25. Ses recherches se concentrent principalement sur les spondyloarthrites, l'arthrite rhumatoïde, le psoriasis, ainsi que les pathologies de la colonne vertébrale et les troubles auto-immuns. Ses travaux publiés sur PubMed couvrent l'épidémiologie, les spondyloarthrites, les traitements anti-IL-17 et anti-IL-23, ainsi que des aspects génétiques.

Expertises présumées

  • Spondyloarthrite
  • Arthrite rhumatoïde
  • Psoriasis
  • Pathologie de la colonne vertébrale
  • Troubles auto-immuns
  • Thérapies anti-IL-17
  • Thérapies anti-IL-23
  • Génétique des maladies rhumatismales

Synthèse automatique à partir des sources publiques (HAL, OpenAlex, theses.fr, ClinicalTrials.gov, FAI²R, ANS). Pas une évaluation clinique. Le médecin peut corriger via son compte.

Diplômes

🎓 DES & spécialité ordinale

  • Rhumatologie (SM)

🎓 Diplômes

  • Diplôme éq d'un pays de l'EEE profession Médecin

📝 Autres formations

  • DEES Rhumatologie

Source : Annuaire Santé ANS (FHIR Practitioner.qualification) · Mises à jour quotidiennes.

Activité de recherche & publications

Source : bases de données publiques (OpenAlex, PubMed).

h-index

25

h articles cités ≥ h fois chacun. Un h de 25 = 25 publications avec 25+ citations.

Citations

3 139

Publications

287

i10-index

71

Thématiques principales

  • Spondyloarthritis Studies and Treatments ×214
  • Rheumatoid Arthritis Research and Therapies ×162
  • Psoriasis: Treatment and Pathogenesis ×62
  • Spine and Intervertebral Disc Pathology ×41
  • Autoimmune and Inflammatory Disorders Research ×30
Voir sur OpenAlex ↗🆔 ORCID 0000-0002-2309-5837

Source : OpenAlex (CC0, OurResearch). Indicateurs académiques agrégés sur 250 M+ d'œuvres.

Bibliographie

Source : HAL — archive ouverte CCSD/CNRS (couvre articles, chapitres EMC, communications congrès, thèses).

Lieu de consultation

Tarifs & secteur de conventionnement

Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).

📊 Comprendre le remboursement

Prendre rendez-vous & contact

🗓 Trouver sur Doctolib📇 Ajouter à mes contacts

Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).

Top publications · les plus citées

  • 1
    Subclinical psoriatic arthritis and disease interception-where are we in 2024?

    Rheumatology (Oxford, England) · 2025

    📚 13 citations🎯 RCR 5.80🔓 Open Access📄 PDF gratuit ↗
    Lire l'abstract Crossref ↓

    Abstract Psoriatic arthritis (PsA) is a chronic rheumatic disease that usually appears in patients with skin psoriasis, making it a model for detection of joint disease in the pre-clinical phases in a setting where therapy for cutaneous disease may ameliorate or prevent arthritis development. Such PsA prevention appears credible due to the increasingly recognized closely shared immunopathology between the skin and joints, especially the entheses. Recently, several initiatives have explored the concept of pre-clinical PsA, and nomenclatures have been developed with the recent EULAR nomenclature proposing a simplified three stages from psoriasis to clinical PsA development, namely at risk of PsA, subclinical PsA and early PsA. A better comprehension of early PsA and the identification of individuals predisposed to its development could enable interventions to ‘prevent’ the appearance of PsA. Several recent retrospective observational studies have demonstrated disease interception feasibility, i.e. treatment of people with psoriasis may prevent the appearance of PsA, in particular using biologic disease-modifying drugs. However, further data are urgently required due to unexpected findings in some studies where TNF inhibition for psoriasis does not reduce the rate of PsA development. In this review we address the current challenges in early PsA, including comparisons of pre-PsA nomenclature sets, its risk factors and the potential for disease interception.

  • 2
    Performance analysis of a deep-learning algorithm to detect the presence of inflammation in MRI of sacroiliac joints in patients with axial spondyloarthritis

    Annals of the rheumatic diseases · 2025

    📚 12 citations🎯 RCR 5.62🩺 Clinique🔓 Open Access📄 PDF gratuit ↗
  • 3
    Ultrasonography for the assessment of enthesitis in psoriatic arthritis: systematic review with meta-analysis

    Rheumatology (Oxford, England) · 2025

    📚 8 citations🎯 RCR 3.74🔓 Open Access📄 PDF gratuit ↗
    Lire l'abstract Crossref ↓

    Abstract Objectives The specificity of US for enthesitis in PsA is unclear. The objective was to analyse the specificity of US enthesitis in Mode B and using power Doppler for the diagnosis of PsA through a systematic review with meta-analysis. Methods Systematic review in PubMed 2010 to June 2023 of studies of adult patients with confirmed PsA with or without a control group of non-PsA patients, reporting information on US enthesitis. Data were analysed on (i) the prevalence of US enthesitis (presence of at least one enthesitis) in PsA patients and non-PsA patients, (ii) specificity and sensitivity of US enthesitis and then specifically power Doppler for PsA diagnosis and (iii) most specific localizations of enthesitis in PsA patients. Pooled percentages and means were evaluated using univariate random effects meta-analysis. Results In 76 articles, 5927 patients with PsA were compared with 3423 controls (59.0% of whom had psoriasis). The prevalence of US enthesitis was 73.7% (95% CI 56.6–90.9%) in PsA patients vs 12.6% (2.6–22.3%) in controls. The pooled specificity and sensitivity of Mode B US were 73.2% (59.3–87.0%) and 62.1% (47.9–76.4%); and of power Doppler, were 97.9% (96.5–99.5%) and 14.7% (8.2–21.2%), respectively. The site most frequently involved in PsA but not in controls was the Achilles tendon, in which erosions and power Doppler activity were most discriminant. Conclusion In this systematic review, US enthesitis was highly prevalent in PsA patients. Evidencing enthesitis by US was found to be reasonably specific and could contribute to the diagnosis of PsA; power Doppler was highly specific, however it was rarely present.

Publications scientifiques (50) — classées par pathologie

Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).

Transversal27

▼

Épidémiologie & registres6

▼

Spondyloarthrite3

▼

Anti-IL-172

▼

Génétique2

▼

Revue générale2

▼

Anti-IL-231

▼

Anti-TNF1

▼

Biomarqueurs / Auto-Ac1

▼

Économie santé1

▼

Essai clinique1

▼

Ostéoporose1

▼

Pharmacovigilance1

▼

Recommandations1

▼

Rhumatisme psoriasique1

▼

Tendinopathies & SCC1

▼

Vraie vie / RWE1

▼

Datasets & protocoles partagés

Source : DataCite — DOIs pour datasets, logiciels, protocoles, registres patient. Hors articles (déjà couverts).

Partager cette fiche

in LinkedIn🟢 WhatsApp✉ Email

Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.